News

AstraZeneca India to invest Rs 250 crore to expand its Global Innovation and Technology Centre

• By Newsdesk
• Chennai
• Jul 04, 2024

News

AstraZeneca India Private Limited (AZIPL) has announced a Rs 250 crore ($30 million) investment to expand its Global Innovation and Technology Centre (GITC) in Chennai, Tamil Nadu. This expansion will create approximately 1,300 roles aimed at fostering innovation, improving efficiency, and streamlining operations globally.

The expanded facility was inaugurated by Dr. TRB Rajaa, Minister of Industries, Tamil Nadu, Christina Scott CMG, British Deputy High Commissioner to India, Sylvia Varela, AstraZeneca Vice President for Asia Area, and AstraZeneca’s leadership team in India.

This investment marks a significant milestone in AstraZeneca’s 45-year journey in India. By 2025, the expanded GITC will introduce highly skilled roles, enhancing the company's ability to utilize technologies such as enterprise platforms, artificial intelligence, machine learning, data science, and supply chain analytics to impact healthcare outcomes.

Dr. Sanjeev Panchal, Managing Director & Country President, AstraZeneca Pharma India Limited (AZPIL), stated, "India’s rich talent pool and dynamic ecosystem for digital advancements make it a pivotal hub for our global operations. This strategic investment underscores our dedication to improving patient outcomes through cutting-edge technology and reinforces our aspiration to transform the future of the healthcare industry."

MK Stalin, Chief Minister of Tamil Nadu, remarked, "Technology drives innovation, and we aim to make Tamil Nadu a technology and research hub. This collaboration with AstraZeneca aligns with our vision to foster innovation and create high-value opportunities for the people of Tamil Nadu. We are dedicated to ensuring Tamil Nadu remains a premier investment destination for global companies.”

Dr. Rajaa added, "AstraZeneca’s decision to expand their facility in Chennai reaffirms their commitment to Tamil Nadu’s exceptional talent pool and business ecosystem. Under the leadership of our Honourable Chief Minister MK Stalin, Chennai has rapidly become the GCC Capital of India, leading to record office space absorption and creating high-quality jobs. We are thrilled that AstraZeneca is part of this growth journey. This investment will boost our state's pharmaceutical and healthcare capabilities while spurring technological advancements and economic development. AstraZeneca’s expansion and talent integration contribute to our vision of making Tamil Nadu a global hub for innovation-driven industries.”